Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group provided updates at the 2019 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. The working group prioritized 4 domains, including musculoskeletal disease activity (enthesitis and dactylitis), fatigue, physical function, and structural damage. In this report, the working group summarizes its progress in standardizing the core outcome set for these 4 domains.

More information Original publication

DOI

10.3899/jrheum.200127

Type

Journal article

Publication Date

2020-06-01T00:00:00+00:00

Volume

96

Pages

46 - 49

Total pages

3

Keywords

GRAPPA, OMERACT, OUTCOME MEASURES, PSORIASIS, PSORIATIC ARTHRITIS, Arthritis, Psoriatic, Enthesopathy, Fatigue, Humans, Outcome Assessment, Health Care, Psoriasis, Reference Standards